Literature DB >> 3301907

Circulating secretory component in breast neoplasms.

D Kvale, T O Rognum, E Thorud, S D Fosså, J S Rø, P Brandtzaeg.   

Abstract

The serum concentrations of IgAp and IgMr associated secretory component (SIgA and SIgM) of 98 patients with neoplasms of the breast were measured. Of the 56 patients with carcinomas, 11 had increased concentrations of circulating SIgM, which was almost twice as sensitive as SIgA as a marker for carcinoma. Concentrations of circulating SIgA and SIgM were independent of expression of secretory component, IgA, and carcinoembryonic antigen (CEA); histological tumour grade; and tumour cell DNA ploidy, whereas a weak correlation between SIgA and SIgM and circulating CEA was seen. The three patients who had liver metastases indicated had particularly high concentrations of circulating SIgA and SIgM, whereas no difference was generally seen between patients with malignancy and those with benign tumours.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301907      PMCID: PMC1141050          DOI: 10.1136/jcp.40.6.621

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Human secretory component--VI. Immunoglobulin-binding properities.

Authors:  P Brandtzaeg
Journal:  Immunochemistry       Date:  1977-03

2.  Synthesis of secretory component by colonic neoplasms.

Authors:  M E Poger; B R Hirsch; M E Lamm
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

3.  Study of secretory component in patients with metastatic breast cancer.

Authors:  E A Puleo; D E Haagensen; J R Dawson; S A Gall
Journal:  Am J Obstet Gynecol       Date:  1979-08-15       Impact factor: 8.661

4.  A direct assay for carcinoembryonic antigen in serum and its diagnostic value in metastatic breast cancer.

Authors:  O Börmer
Journal:  Clin Biochem       Date:  1982-06       Impact factor: 3.281

5.  Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis.

Authors:  D Kvale; T O Rognum; P Brandtzaeg
Journal:  Cancer       Date:  1987-01-15       Impact factor: 6.860

6.  Reassessment of levels of secretory IgA in pathological sera using a quantitative radioimmunoassay.

Authors:  D Delacroix; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

7.  Secretory-component-producing lung cancer with hypergammaglobulinemia of secretory IgA.

Authors:  T Gotoh; Y Takishita; H Doi; E Tsubura
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

8.  Plasma carcinoembryonic antigen concentrations and immunohistochemical patterns of epithelial marker antigens in patients with large bowel carcinoma.

Authors:  T Rognum; K Elgjo; P Brandtzaeg; H Orjasaeter; A Bergan
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

9.  Secretory component: a glandular epithelial cell marker.

Authors:  J P Harris; M A South
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

10.  Differentiation of human breast carcinomas: an immunohistological study of appropriate and inappropriate protein production.

Authors:  R A Walker
Journal:  J Pathol       Date:  1981-09       Impact factor: 7.996

View more
  2 in total

1.  Secretory component in differentiating normal epithelium, benign lesions and malignancy in the human breast as monitored by monoclonal antibodies.

Authors:  J Bártek; H Tlaskalová-Hogenová; Z Stasková; J Simecková; B Vojtĕsek; A Rejthar; J Kovarík; J Bartková
Journal:  Histochemistry       Date:  1989

2.  Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma.

Authors:  M Rossel; C Billerey; H Bittard; P Ksiazek; D Alber; J P Revillard; D A Vuitton
Journal:  Urol Res       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.